These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Relationship between expression of caveolin-1 and pERK1/2 and prognosis in non-small cell lung cancer]. Liu HX, Xing LX, Wang HB, Yang JQ, Sun YM. Zhonghua Bing Li Xue Za Zhi; 2008 Sep; 37(9):615-9. PubMed ID: 19094586 [Abstract] [Full Text] [Related]
9. 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. Zöchbauer-Müller S, Fong KM, Maitra A, Lam S, Geradts J, Ashfaq R, Virmani AK, Milchgrub S, Gazdar AF, Minna JD. Cancer Res; 2001 May 01; 61(9):3581-5. PubMed ID: 11325823 [Abstract] [Full Text] [Related]
11. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance. Nakata S, Sugio K, Uramoto H, Oyama T, Hanagiri T, Morita M, Yasumoto K. Cancer; 2006 May 15; 106(10):2190-9. PubMed ID: 16598757 [Abstract] [Full Text] [Related]
12. Increased expression of 17-beta-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer. Drzewiecka H, Gałęcki B, Jarmołowska-Jurczyszyn D, Kluk A, Dyszkiewicz W, Jagodziński PP. Lung Cancer; 2015 Feb 15; 87(2):107-16. PubMed ID: 25564397 [Abstract] [Full Text] [Related]
13. [Significance of caveolin-1 expression in primary lung cancer]. Yu JH, Wei Q, Qi FJ, Xu HT, Wang EH. Zhonghua Bing Li Xue Za Zhi; 2006 Nov 15; 35(11):664-8. PubMed ID: 17374210 [Abstract] [Full Text] [Related]
16. DNA methylation markers and early recurrence in stage I lung cancer. Brock MV, Hooker CM, Ota-Machida E, Han Y, Guo M, Ames S, Glöckner S, Piantadosi S, Gabrielson E, Pridham G, Pelosky K, Belinsky SA, Yang SC, Baylin SB, Herman JG. N Engl J Med; 2008 Mar 13; 358(11):1118-28. PubMed ID: 18337602 [Abstract] [Full Text] [Related]
17. Significance of methylation status and the expression of RECK mRNA in lung tissue of patients with NSCLC. Pesta M, Kulda V, Topolcan O, Safranek J, Vrzalova J, Cerny R, Holubec L. Anticancer Res; 2009 Nov 13; 29(11):4535-9. PubMed ID: 20032402 [Abstract] [Full Text] [Related]
18. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Kim DH, Nelson HH, Wiencke JK, Zheng S, Christiani DC, Wain JC, Mark EJ, Kelsey KT. Cancer Res; 2001 Apr 15; 61(8):3419-24. PubMed ID: 11309302 [Abstract] [Full Text] [Related]
19. Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer. Kikuchi S, Yamada D, Fukami T, Masuda M, Sakurai-Yageta M, Williams YN, Maruyama T, Asamura H, Matsuno Y, Onizuka M, Murakami Y. Clin Cancer Res; 2005 Apr 15; 11(8):2954-61. PubMed ID: 15837747 [Abstract] [Full Text] [Related]
20. Aberrant methylation of FBN2 in human non-small cell lung cancer. Chen H, Suzuki M, Nakamura Y, Ohira M, Ando S, Iida T, Nakajima T, Nakagawara A, Kimura H. Lung Cancer; 2005 Oct 15; 50(1):43-9. PubMed ID: 15951052 [Abstract] [Full Text] [Related] Page: [Next] [New Search]